This announcement is a separate document:
李氏大藥廠:自願性公佈 - 重組安菲博肽注射液或獲得臨床試驗藥物申請受理通知書
LEE'S PHARM: Voluntary Announcement - Potential Acceptance Notice of Investigational New Drug Application of Recombinant Anfibatide Injection
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.